Welcome to the Deininger Lab

As a physician, Dr. Deininger's expertise is in the treatment of leukemia. As a scientist, his research program focuses on the biology of myeloproliferative neoplasms and the development of molecularly targeted therapies. The lab is especially interested in understanding the molecular mechanisms of resistance to tyrosine kinase inhibitors such as imatinib, a drug used to treat chronic myeloid leukemia and some other types of cancer.